Feb 14, 2024 4:05 pm EST Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
Feb 13, 2024 4:05 pm EST Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
Feb 01, 2024 4:05 pm EST seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
Dec 27, 2023 8:30 am EST Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
Dec 13, 2023 4:06 pm EST Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
Dec 13, 2023 4:05 pm EST Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
Dec 11, 2023 7:05 am EST Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing
Nov 28, 2023 4:05 pm EST Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023
